Latest Transformation News

Meeka Metals has begun commissioning its processing plant at the Murchison Gold Project, with ore now feeding into the plant and the first gold pour expected in June 2025.

Black Canyon Limited is set to significantly broaden its footprint in the eastern Pilbara with the acquisition of 229 square kilometres of new tenements around its Wandanya manganese project, enhancing its potential for large-scale manganese and iron mineralisation.

EVE Health Group has launched a $1.5 million capital raise alongside the acquisition of biotech firm Nextract, aiming to expand its footprint in health and pharmaceutical products focused on erectile dysfunction and period pain.

FOS Capital has secured $3.7 million through a placement to fund its acquisition of Aldridge Traffic Systems, aiming to expand its footprint in the Australian lighting market. The deal includes key assets and intellectual property, positioning FOS for accelerated growth.

Cokal Limited has secured US$15 million in strategic debt funding to ramp up metallurgical coal production at its BBM mine, while terminating all agreements with Cratus due to non-performance.

Resolution Minerals Ltd has entered a binding agreement to acquire the Horse Heaven Project in Idaho, a promising antimony-gold-silver-tungsten asset adjacent to a major US mine, with drilling planned for 2025.

PYC Therapeutics has secured Safety Review Committee approval to increase dosing in its clinical trial for a novel treatment targeting Autosomal Dominant Optic Atrophy, a rare blinding genetic disease. This milestone marks a significant step forward in the development of PYC-001, a first-in-class RNA therapy.

Celsius Resources’ Philippine subsidiary has launched a detailed drilling campaign to refine the feasibility and engineering plans for its flagship copper-gold project, aiming to unlock further value and operational clarity.

Freehill Mining has expanded its footprint in Chile’s La Serena region by securing a third site to increase aggregate production capacity, supporting major infrastructure projects and funding future magnetite mining operations.

Olympus Corporation has launched a nationwide emphysema screening campaign in the US powered by 4DMedical’s AI lung density analysis, marking a major commercial milestone for the Australian medtech firm.

Helia Group announces the departure of CEO Pauline Blight-Johnston after five years, appointing CFO Michael Cant as interim CEO amid evolving market conditions. The leadership change signals a strategic pivot for the lender mortgage insurer.

Radiopharm Theranostics has secured FDA Fast Track designation for RAD101, a novel imaging agent aimed at improving diagnosis of recurrent brain metastases. The move could speed development and regulatory review as the company advances its Phase 2 clinical trial.